Grindeks has successfully completed the Phase 1 Clinical Study of Its New Investigational Medicinal Product Methyl-GBB

Category: News

fons2

Grindeks has successfully completed the Phase 1 Clinical Study of Its New Investigational Medicinal Product Methyl-GBB

JSC Grindeks announces that it has completed the Phase 1 clinical study of its new investigational medicinal product metyl-GBB. This new investigational medicinal product is...
05/03/2020
fons

Profit of Grindeks reaches 12.9 million euro in 2019

Today, on 28 February, the JSC Grindeks submitted the non-audited consolidated financial statements of 2019 to Nasdaq Riga. Non-audited financial results indicate that the Group’s...
28/02/2020
ampula

Regarding changes in the Management Board of Grindeks subsidiary Kalceks

As of February 18, the Management Board of JSC Kalceks, a subsidiary of JSC Grindeks, has been changed – the member of the Management Board...
19/02/2020
On Grindeks financial results in the three months

Juris Hmelnickis appointed as the Chairman of the Board of Grindeks

JSC Grindeks announces that the company’s Supervisory Council has approved Juris Hmelnickis as the Chairman of the Board. Kirovs Lipmans, Chairman of the Council of...
04/02/2020
imgRandom

The Ambassador of Benin to Latvia visits Grindeks

On Friday, January 17, Ambassador Extraordinary and Plenipotentiary of the Republic of Benin to Latvia, Eusebe Agbangla and Honorary Consul of the Republic of Benin,...
17/01/2020
Saudi Food and Drug Authority

JSC Grindeks receives a certificate of Saudi Food and Drug Authority

JSC Grindeks informs that the company has received a certification of Saudi Food and Drug Authority certifying the compliance of Grindeks final dosage forms –tablets...
19/12/2019
The Ambassador of Japan to Latvia visits Grindeks

The Ambassador of Japan to Latvia visits Grindeks

On Tuesday, December 3, Ambassador Extraordinary and Plenipotentiary of Japan to Latvia Yasuhiro Kawaguchi and Attaché of Japanese Embassy in Latvia Kentaro Morimoto visited JSC...
03/12/2019
Molekulas

Grindeks profit in the first nine months of 2019 increases by 17% and reaches 8.9 million euro

Today, on November 28, JSC Grindeks submitted the non-audited consolidated financial statements of the first nine months of 2019 to Nasdaq Riga. Non-audited financial results...
29/11/2019
Grindeks product Viprosal B

Grindeks product Viprosal B® receives „Russian Pharma Awards”® recognition

On November 14 in Russia’s capital city Moscow the eighth pharmaceutical industry product competition “Russian Pharma Awards”® ceremony was held during which Grindeks product Viprosal...
21/11/2019
Grindeks and Kalceks will participate in

Grindeks and Kalceks will participate in the world’s largest pharmaceutical exhibition “CPhI Worldwide 2019

From November 5 to 7 in Frankfurt (Germany), one of the most anticipated events in pharmacy – exhibition “CPhI Worldwide 2019” – will take place....
04/11/2019
Grindeks oxytocin inclusion in WHO

Grindeks oxytocin inclusion in WHO List of Prequalified Medicinal Products provides new opportunities in international tenders

JSC Grindeks informs that World Health Organization (WHO) has included oxytocin solution for injection 10 IU/ml in the List of Prequalified Medicinal Products. JSC Grindeks...
22/10/2019
backgroundImg10

Grindeks congratulates winners of the International Chemistry Olympiad

On Friday, October 4, in Riga Castle, an awarding ceremony took place to honour participants of International Subjects Olympiads. By continuing to support new talents...
07/10/2019
Children neurologist Jurģis Strautmanis

Children neurologist Jurģis Strautmanis receives Grindeks highest professional honor D. H. Grindel award

On Friday, October 4, in The Large Hall of Latvian Union House, as part of Children’s Clinical University Hospital’s 120 years anniversary, children neurologist, electroencephalography...
07/10/2019
backgroundImg9

JSC Grindeks supports Children’s Clinical University Hospital 120th years’ anniversary activities

Today in Children’s Clinical University Hospital’s Sunny Days Library, presentation on hospital’s 120th years anniversary events will take place. JSC “Grindeks” has become a supporter...
02/10/2019
backgroundImg8

Grindeks profit in the first six months of 2019 increases by 14% and reaches 7.65 million euro

Today, on August 29, JSC Grindeks submitted the non-audited consolidated financial statements of the first six months of 2019 to Nasdaq Riga. Non-audited financial results...
29/08/2019
magnifiercrossmenu